The Hartford Healthcare Fund Class A (HGHAX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.77: the stock has moved about 23% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerThe Hartford Healthcare Fund Class A (HGHAX) trades at $41.17. The Hartford Healthcare Fund Class A (HGHAX) is a mutual fund focused on long-term capital appreciation through investments in healthcare-related companies worldwide. Sector: Financials.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for HGHAX: HGHAX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
The Hartford Healthcare Fund Class A (HGHAX) Financial Services Profile
The Hartford Healthcare Fund Class A (HGHAX) is a financial services fund with an $0.84 billion market cap that invests in global healthcare equities, including pharmaceuticals, biotechnology, and medical services, aiming for long-term capital appreciation under the guidance of Wellington Management Company LLP.
What Is the Investment Thesis for HGHAX?
The Hartford Healthcare Fund Class A (HGHAX) presents an investment opportunity in the growing global healthcare sector. With a beta of 0.77, the fund exhibits moderate volatility compared to the broader market. The fund's strategy of investing across diverse healthcare subsectors, guided by Wellington Management, aims to capture growth opportunities while mitigating risk. The absence of a dividend yield focuses returns on capital appreciation. Key catalysts include advancements in healthcare technology and increasing global healthcare spending. Potential risks include regulatory changes and market volatility affecting the healthcare sector.
Based on FMP financials and quantitative analysis
HGHAX Key Highlights
The fund invests at least 80% of its assets in equity securities of health care-related companies worldwide.
- The fund is sub-advised by Wellington Management Company LLP.
- The fund takes a broad approach to investing in the health care sector, including pharmaceuticals, biotechnology and medical services.
- The fund has a market capitalization of $0.84 billion.
- The fund has a beta of 0.77.
Who Are HGHAX's Competitors?
HGHAX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BAMPX BlackRock 40/60 Target Allocation Fund, Investor A | $14.31 | +0.28% | $818M | — |
| CIMDX CLARKSTON FOUNDERS FUND, Institutional Class | $16.62 | -0.06% | $784M | — |
| EEMAX Columbia Emerging Markets Fund Class A | $21.69 | -0.64% | $978M | — |
| FAMEX FAM Dividend Focus Fund Investor | $54.10 | +0.28% | $617M | — |
| GCEQX Green Century Equity Fund - Investor Class | $117.05 | -0.43% | $860M | — |
| BLK BlackRock, Inc. | $1069.63 | -0.91% | $166B | 52 5-pillar |
| BX Blackstone Inc. | $111.82 | -1.36% | $135B | 69 5-pillar |
| APOS Apollo Global Management, Inc. | $25.50 | -0.39% | $74.6B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HGHAX's Key Strengths?
Diversified investments across the healthcare sector.
- Experienced sub-adviser (Wellington Management Company LLP).
- Focus on long-term capital appreciation.
- Global investment approach.
What Are HGHAX's Weaknesses?
Reliance on the expertise of the sub-adviser.
- Potential for market volatility in the healthcare sector.
- Absence of dividend yield may not appeal to all investors.
- Fund performance is subject to market conditions and investment decisions.
What Are the Key Risks for HGHAX?
Regulatory changes in the healthcare industry, such as drug pricing reforms, impacting profitability.
- Market volatility in the healthcare sector due to factors such as clinical trial failures and economic downturns.
- Competition from other healthcare-focused investment funds, potentially impacting fund performance.
What Are HGHAX's Competitive Advantages?
- Expertise of Wellington Management Company LLP in healthcare investing.
- Diversification across various healthcare subsectors and geographic regions.
- Established track record of long-term capital appreciation (if available in source data).
What Does HGHAX Do?
The Hartford Healthcare Fund Class A (HGHAX) is a mutual fund designed for investors seeking long-term capital appreciation through strategic investments in the global healthcare sector. Managed under normal circumstances by Wellington Management Company LLP, the fund allocates at least 80% of its assets to equity securities of healthcare-related companies worldwide. The fund adopts a broad investment approach, encompassing various subsectors within healthcare, including pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed healthcare, health information services, and emerging health-related areas. The fund's investment strategy focuses on identifying companies with strong growth potential and sustainable competitive advantages within the healthcare industry. By diversifying across different healthcare subsectors and geographic regions, the fund aims to mitigate risk and capture opportunities across the entire healthcare value chain. The Hartford Healthcare Fund Class A seeks to provide investors with exposure to the dynamic and evolving healthcare landscape, driven by factors such as technological advancements, demographic shifts, and increasing healthcare spending globally.
What Products and Services Does HGHAX Offer?
- Invests primarily in equity securities of healthcare-related companies.
- Targets long-term capital appreciation.
- Focuses on companies worldwide.
- Invests across various healthcare subsectors, including pharmaceuticals, biotechnology, and medical services.
- Utilizes the expertise of Wellington Management Company LLP as a sub-adviser.
- Takes a broad approach to investing in the healthcare sector.
How Does HGHAX Make Money?
- The fund generates revenue through capital appreciation of its investments in healthcare companies.
- Management fees are charged based on the fund's assets under management (AUM).
- The fund's performance is driven by the investment decisions of the sub-adviser, Wellington Management Company LLP.
What Industry Does HGHAX Operate In?
The Hartford Healthcare Fund Class A operates within the asset management industry, focusing specifically on the healthcare sector. The global healthcare market is experiencing growth, driven by factors such as an aging population, technological advancements, and increasing healthcare spending in emerging markets. The fund competes with other healthcare-focused investment funds and general equity funds. The competitive landscape includes firms like BAMPX, CIMDX, EEMAX, FAMEX, and GCEQX, each with its own investment strategy and risk profile.
Who Are HGHAX's Key Customers?
- Individual investors seeking long-term capital appreciation.
- Institutional investors looking for exposure to the healthcare sector.
- Retirement savers investing through 401(k)s and other retirement accounts.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 43 snapshots
| 2026-08-23 | 47 |
| 2026-08-31 | 47 |
| 2026-09-08 | 47 |
| 2026-09-16 | 47 |
| 2026-09-24 | 47 |
| 2026-10-04 | 47 |
| 2026-10-06 | 47 |
What changed?
The score has stayed at 47.
Over the same 30 days the stock moved -4.0%.
HGHAX Financials
Bull Case vs Bear Case
Bull Case
- Diversified investments across the healthcare sector.
- Experienced sub-adviser (Wellington Management Company LLP).
- Focus on long-term capital appreciation.
- Global investment approach.
Bear Case
- Reliance on the expertise of the sub-adviser.
- Potential for market volatility in the healthcare sector.
- Absence of dividend yield may not appeal to all investors.
- Fund performance is subject to market conditions and investment decisions.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
HGHAX Latest News
No recent news available for HGHAX.
HGHAX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for HGHAX.
Price Targets
Wall Street price target analysis for HGHAX.
HGHAX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for HGHAX; grades run from A+ (80-100) to F (below 30).
Common Questions About HGHAX (Financials)
What are the main risks for HGHAX?
The Hartford Healthcare Fund Class A (HGHAX) faces several risks inherent to the healthcare sector and financial markets. Regulatory changes, such as drug pricing reforms or changes to healthcare policies, can significantly impact the profitability of companies within the fund's portfolio.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The information provided is based on the available source data and is intended for informational purposes only. It does not constitute investment advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.